InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.19
(
0.07%
)
Bitcoin
64,335.19
(
0.53%
)
Post# of 6034
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

dia76ca

Send PM Follow Ignore
Followers 57
Posts 5697
Boards Moderated 0
Alias Born 12/13/2004

dia76ca

Re: dia76ca post# 2141

Wednesday, 06/14/2017 12:40:52 PM

Wednesday, June 14, 2017 12:40:52 PM

Post# of 6034
As well as improving the May 30 company presentation with a sharp focus on turning COLD tumours into HOT...they seem to have cleaned up the website to indicate the focus on HS-110...removing a section on HS-410 which is now clearly on the back-burner. See...

http://www.heatbio.com/pipeline/hs-110

They seem also to have, if my memory serves me, renewed interest in the phase II HS-110 plus low dose cyclophosphamide trial. While this trial does not include a checkpoint inhibitor...low dose CP has been used in a number of CAR-T trials as a primer as it shifts the immune system balance in favour of attacking the tumour. I could easily foresee a triple combination low dose CP + HS-110 + checkpoint inhibitor trial as one of the next combination trials.

"The refusal of the real is the number one dogma of our time" Rene Girard

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NHWK News
More NHWK News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!